Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Is Exservan a film for ALS?

See the DrugPatentWatch profile for Exservan

What does Exservan treat?

Exservan, also known as riluzole, is an oral pharmaceutical drug used to treat amyotrophic lateral sclerosis (ALS) in adults 1. It is an oral medication that has been approved by the FDA for the treatment of ALS in the United States.

Is Exservan a film for ALS?

While Exservan is not specifically a "film" in the classical sense, there are film-coated tablets available for oral administration 2. The film coating is designed to aid in swallowing and to ensure consistent release of the active ingredient, riluzole, in the body.

How does Exservan work?

The exact mechanism of Exservan in treating ALS is not fully understood; it is thought to have neuroprotective effects, possibly by blocking the release of certain chemicals in the brain such as glutamate, which can be toxic to nerve cells 3.

Regulatory approval and patent status

In the United States, Exservan was first approved in 1995 and has maintained its status as an FDA-approved treatment for ALS 4. However, its exclusivity has expired or been waived 5, allowing other companies to develop generics and biosimilars.

Sources: